Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Beximco To Be Exclusive Covid Vaccine Supplier In Bangladesh

28th Aug 2020 14:33

Beximco Pharmaceuticals PLC - Bangladesh-based medicine manufacturer - Partners with vaccine producer Serum Institute of India Pvt Ltd on cooperation and distribution agreement to develop Covid-19 vaccine, for which Beximco will be the exclusive supplier in Bangladesh. Serum has partnered with AsstraZeneca PLC, Gates Foundation and Gavi to producer more than billion doses of a vaccine for global supply.

Current stock price: 60.25 pence

Year-to-date change: up 31%

By Dayo Laniyan; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

AstrazenecaBeximco Pharma
FTSE 100 Latest
Value8,809.74
Change53.53